205 related articles for article (PubMed ID: 19767314)
1. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.
Segura PP; Gil M; Balañá C; Chacón I; Langa JM; Martín M; Bruna J
J Neurooncol; 2012 Aug; 109(1):137-42. PubMed ID: 22610937
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
7. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
Giorgio CG; Giuffrida D; Pappalardo A; Russo A; Santini D; Salice P; Blanco G; Castorina S; Failla G; Bordonaro R
Lung Cancer; 2005 Nov; 50(2):247-54. PubMed ID: 16039010
[TBL] [Abstract][Full Text] [Related]
8. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.
Abrey LE; Olson JD; Raizer JJ; Mack M; Rodavitch A; Boutros DY; Malkin MG
J Neurooncol; 2001 Jul; 53(3):259-65. PubMed ID: 11718258
[TBL] [Abstract][Full Text] [Related]
10. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
[TBL] [Abstract][Full Text] [Related]
11. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
[TBL] [Abstract][Full Text] [Related]
12. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
[TBL] [Abstract][Full Text] [Related]
13. Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study.
Schadendorf D; Hauschild A; Ugurel S; Thoelke A; Egberts F; Kreissig M; Linse R; Trefzer U; Vogt T; Tilgen W; Mohr P; Garbe C
Ann Oncol; 2006 Oct; 17(10):1592-7. PubMed ID: 17005632
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
Omuro AM; Raizer JJ; Demopoulos A; Malkin MG; Abrey LE
J Neurooncol; 2006 Jul; 78(3):277-80. PubMed ID: 16614943
[TBL] [Abstract][Full Text] [Related]
15. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
[TBL] [Abstract][Full Text] [Related]
16. Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin
He Q; Bi X; Ren C; Wang Y; Zou P; Zhang H; Chi N; Xiu C; Wang Y; Tao R
Anticancer Res; 2017 Aug; 37(8):4711-4716. PubMed ID: 28739776
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
[TBL] [Abstract][Full Text] [Related]
18. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
Ebert BL; Niemierko E; Shaffer K; Salgia R
Oncologist; 2003; 8(1):69-75. PubMed ID: 12604733
[TBL] [Abstract][Full Text] [Related]
19. The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.
Bafaloukos D; Tsoutsos D; Fountzilas G; Linardou H; Christodoulou C; Kalofonos HP; Briassoulis E; Panagiotou P; Hatzichristou H; Gogas H
Melanoma Res; 2004 Aug; 14(4):289-94. PubMed ID: 15305160
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
Christodoulou C; Bafaloukos D; Linardou H; Aravantinos G; Bamias A; Carina M; Klouvas G; Skarlos D;
J Neurooncol; 2005 Jan; 71(1):61-5. PubMed ID: 15719277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]